Form 4: Teladoc Health Director Acquires Restricted Stock Units
SEC Form 4 Filing
Director Mark Douglas Smith acquired 17,467 restricted stock units in Teladoc Health, Inc. on May 23, 2024.
Summary
- On May 23, 2024, Mark Douglas Smith, a director of Teladoc Health, Inc., acquired 17,467 restricted stock units (RSUs).
- Each RSU represents the right to receive one share of TDOC common stock.
- The RSUs vest in full on the earlier of May 23, 2025, or the day before the company's 2025 annual meeting of stockholders.
- Vested shares will be delivered under certain conditions, including separation of service, a change of control, or the reporting person's death.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock unit grants, which is neutral in sentiment.
Future Outlook
The vesting of the restricted stock units is contingent upon continued service or specific events such as a change of control or death.
Industry Context
This is a standard practice for compensating directors and aligning their interests with those of the shareholders.
Stakeholder Impact
- The acquisition of restricted stock units by a director aligns their interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/23/2024 | Date of transaction: Mark Douglas Smith acquired restricted stock units. |
| 05/23/2025 | Earliest vesting date for the restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.